Clinical Trial Update: First-line Bosentan and Sildenafil Combination Therapy for Pulmonary Arterial Hypertension

View source ↗

Summary

The document reports on a completed clinical trial evaluating first-line combination therapy with bosentan and sildenafil for pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Bosentan (Bosentan)
• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University of Calgary | Conditions: Hypertension, Pulmonary | Status: COMPLETED